Cargando…

Predictors of mortality in interstitial lung disease patients without pulmonary hypertension

BACKGROUND: There is a paucity of information regarding prognostic factors associated with reduced survival in interstitial lung disease (ILD) patients without pulmonary hypertension (PH). AIMS: The aim of this study was to determine physiological and hemodynamic parameters that impact survival amon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alhamad, Esam H., Cal, Joseph G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720737/ https://www.ncbi.nlm.nih.gov/pubmed/33381239 http://dx.doi.org/10.4103/atm.ATM_438_20

Ejemplares similares

Predictors of Mortality in Patients with Interstitial Lung Disease-Associated Pulmonary Hypertension
por: Alhamad, Esam H., et al.
Publicado: (2020)

Acute exacerbation in interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Interstitial lung diseases in Saudi Arabia: A single-center study
por: Alhamad, Esam H.
Publicado: (2013)

Familial interstitial lung disease in four members of one family: a case series
por: Alhamad, Esam H
Publicado: (2009)

Clinical characteristics and outcomes in patients with primary Sjogren's syndrome-associated interstitial lung disease
por: Alhamad, Esam H., et al.
Publicado: (2021)

Pulmonary hypertension in Saudi Arabia: A single center experience
por: Alhamad, Esam H., et al.
Publicado: (2013)

Cytokine gene polymorphisms and serum cytokine levels in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H, et al.
Publicado: (2013)

Noninvasive determinants of pulmonary hypertension in interstitial lung disease
por: Joseph, Phillip, et al.
Publicado: (2023)

The six-minute walk test in patients with pulmonary sarcoidosis
por: Alhamad, Esam H.
Publicado: (2009)

Clinical characteristics, comorbidities, and outcomes in patients with idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2020)

Pulmonary Artery Size in Interstitial Lung Disease and Pulmonary Hypertension: Association with Interstitial Lung Disease Severity and Diagnostic Utility
por: Chin, Matthew, et al.
Publicado: (2018)

Predictors of Mortality in Progressive Fibrosing Interstitial Lung Diseases
por: Chen, Xianqiu, et al.
Publicado: (2021)

Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis
por: Fairley, Jessica L., et al.
Publicado: (2023)

Depression in Pulmonary Arterial Hypertension and Interstitial Lung Diseases
por: Verma, Sameer, et al.
Publicado: (2014)

Predictors of mortality in subjects with progressive fibrosing interstitial lung diseases
por: Brown, Kevin K., et al.
Publicado: (2022)

Sarcoidosis-associated pulmonary hypertension: Clinical features and outcomes in Arab patients
por: Alhamad, Esam H., et al.
Publicado: (2010)

Pirfenidone treatment in idiopathic pulmonary fibrosis: A Saudi experience
por: Alhamad, Esam H.
Publicado: (2015)

Recent advances in the management of pulmonary hypertension with interstitial lung disease
por: Waxman, Aaron B., et al.
Publicado: (2022)

Response to letter to the editor “noninvasive determinants of pulmonary hypertension in interstitial lung disease”
por: Joseph, Phillip, et al.
Publicado: (2023)

MORTALITY AND ITS PREDICTORS IN PATIENTS WITH COVID-19 WITH PREEXISTING INTERSTITIAL LUNG DISEASE
por: DUTT, N., et al.
Publicado: (2022)

Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
por: Haynes, Zachary A., et al.
Publicado: (2023)

Clinical Retrospective Analysis of Interstitial Lung Disease Patients Associated with Pulmonary Hypertension
por: Lv, Hongxia, et al.
Publicado: (2019)

Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
por: Parikh, Raj, et al.
Publicado: (2022)

Advanced interstitial lung fibrosis with emphysema and pulmonary hypertension with no evidence for interstitial lung disease on high resolution CT
por: Foris, Vasile, et al.
Publicado: (2019)

Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need
por: Dhont, Sebastiaan, et al.
Publicado: (2022)

Mortality and Its Predictors in COVID-19 Patients With Pre-existing Interstitial Lung Disease
por: Dutt, Naveen, et al.
Publicado: (2022)

Chronic obstructive pulmonary disease lost in translation: Why are the inhaled corticosteroids skeptics refusing to go?
por: AI-Kassimi, Faisal A., et al.
Publicado: (2013)

Ventilation distribution as a contributor to the functional exercise capacity in patients with systemic sclerosis-associated interstitial lung disease without pulmonary hypertension
por: Andrade, F.M., et al.
Publicado: (2019)

Re: Prevalence of chronic obstructive pulmonary disease among smokers attending primary health-care clinics in Saudi Arabia
por: Al-Kassimi, Feisal A., et al.
Publicado: (2011)

Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
por: Rahaghi, Franck F., et al.
Publicado: (2022)

Interstitial lung disease and pre-capillary pulmonary hypertension in neurofibromatosis type 1
por: Rodrigues, Daniela, et al.
Publicado: (2018)

Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension
por: Guillén-Del-Castillo, Alfredo, et al.
Publicado: (2022)

A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease
por: Bax, Simon, et al.
Publicado: (2018)

Predictors of progression in systemic sclerosis patients with interstitial lung disease
por: Distler, Oliver, et al.
Publicado: (2020)

Survival predictors of interstitial lung disease in India: Follow-up of Interstitial Lung Disease India registry
por: Singh, Sheetu, et al.
Publicado: (2021)

Echocardiographic Predictors of Mortality in Patients with Pulmonary Hypertension and Cardiopulmonary Comorbidities
por: Steiner, Johannes, et al.
Publicado: (2015)

Pulmonary hypertension due to unclassified interstitial lung disease in a Pembroke Welsh corgi
por: MORITA, Tomoya, et al.
Publicado: (2018)

Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
por: Behr, Jürgen
Publicado: (2021)

The Challenge of Diagnosing and Managing Pulmonary Arterial Hypertension in Systemic Sclerosis with Interstitial Lung Disease
por: Zanatta, Elisabetta, et al.
Publicado: (2022)

Pulmonary Hypertension in Interstitial Lung Disease: Management Options to Move Beyond Supportive Care
por: Fabyan, Kimberly D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9apu48811kjms31qdcval31h0p